Literature DB >> 25851497

Dysregulated microRNAs involved in the progression of cervical neoplasm.

Kangkang Zeng1, Wenjing Zheng, Xianglan Mo, Fei Liu, Meiyi Li, Zhen Liu, Wei Zhang, Xiaoxia Hu.   

Abstract

PURPOSE: MicroRNAs (miRNAs) exhibit dysregulated expression in human cancer and play an important role in carcinogenesis. The aim of this study was to identify a distinct miRNA expression signature for cervical cancer and cervical intraepithelial neoplasia (CIN) and to investigate the function of deregulated miRNAs in cervical carcinoma.
METHODS: A miRNA microarray was used to compare miRNA expression profiles in cervical cancer, CIN and normal cervical tissues. Real-time RT-PCR was used to validate the expression of 9 miRNAs in 103 cervical tissues. Bioinformatics programs were used to predict potential target genes and their function. Functional studies were performed to characterize the effect on cervical cancer cells by overexpression of miR-218 and miR-21.
RESULTS: We identified deregulated miRNAs in cervical cancer and high-grade squamous intraepithelial lesions (HSIL). MiR-218 was the most downregulated (0.175-fold decrease) miRNA, and miR-21 was the most upregulated (5.67-fold increase) miRNA. In addition, the expression patterns of 9 miRNAs were validated by real-time RT-PCR. Bioinformatics analyses and functional studies indicated that miR-218 and miR-21 may be involved in cancer invasion and metastasis.
CONCLUSION: Our study demonstrated that miRNAs are aberrantly expressed in cervical cancer and cervical preneoplastic lesions. These miRNAs may be involved in the progression of cervical neoplasm as potential tumor suppressor genes or oncogenes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25851497     DOI: 10.1007/s00404-015-3702-5

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  16 in total

1.  MicroRNA-10b inhibits proliferation, migration and invasion in cervical cancer cells via direct targeting of insulin-like growth factor-1 receptor.

Authors:  Ren Hou; Daixian Wang; Jian Lu
Journal:  Oncol Lett       Date:  2017-04-13       Impact factor: 2.967

Review 2.  The Dysregulation of MicroRNAs in the Development of Cervical Pre-Cancer-An Update.

Authors:  Pui-Wah Choi; Tin Lun Liu; Chun Wai Wong; Sze Kei Liu; Yick-Liang Lum; Wai-Kit Ming
Journal:  Int J Mol Sci       Date:  2022-06-27       Impact factor: 6.208

3.  MiR-361-5p suppresses chemoresistance of gastric cancer cells by targeting FOXM1 via the PI3K/Akt/mTOR pathway.

Authors:  Lei Tian; Zhifeng Zhao; Ling Xie; JinPeng Zhu
Journal:  Oncotarget       Date:  2017-12-20

4.  MicroRNA-326 suppresses the proliferation, migration and invasion of cervical cancer cells by targeting ELK1.

Authors:  Ping Zhang; Feng Kong; Xinchao Deng; Yunhai Yu; Congzhe Hou; Tingting Liang; Lin Zhu
Journal:  Oncol Lett       Date:  2017-03-13       Impact factor: 2.967

5.  miRNA Expression Profiles of HPV-Infected Patients with Cervical Cancer in the Uyghur Population in China.

Authors:  Dongmei Gao; Yuanyuan Zhang; Mingyue Zhu; Shuang Liu; Xinling Wang
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

6.  MicroRNAs as markers of progression in cervical cancer: a systematic review.

Authors:  Barbara Pardini; Daniela De Maria; Antonio Francavilla; Cornelia Di Gaetano; Guglielmo Ronco; Alessio Naccarati
Journal:  BMC Cancer       Date:  2018-06-27       Impact factor: 4.430

Review 7.  Human Papillomavirus Infections, Cervical Cancer and MicroRNAs: An Overview and Implications for Public Health.

Authors:  Michela Lucia Sammarco; Manuela Tamburro; Alessandra Pulliero; Alberto Izzotti; Giancarlo Ripabelli
Journal:  Microrna       Date:  2020

8.  MicroRNA-218-5p inhibits cell growth and metastasis in cervical cancer via LYN/NF-κB signaling pathway.

Authors:  Yunsheng Xu; Qin He; Yiyi Lu; Fengxing Tao; Liang Zhao; Rongying Ou
Journal:  Cancer Cell Int       Date:  2018-12-04       Impact factor: 5.722

9.  MicroRNA-331-3p Suppresses Cervical Cancer Cell Proliferation and E6/E7 Expression by Targeting NRP2.

Authors:  Tomomi Fujii; Keiji Shimada; Aya Asano; Yoshihiro Tatsumi; Naoko Yamaguchi; Masaharu Yamazaki; Noboru Konishi
Journal:  Int J Mol Sci       Date:  2016-08-18       Impact factor: 5.923

10.  Triage of high-risk HPV-positive women in population-based screening by miRNA expression analysis in cervical scrapes; a feasibility study.

Authors:  Iris Babion; Barbara C Snoek; Putri W Novianti; Annelieke Jaspers; Nienke van Trommel; Daniëlle A M Heideman; Chris J L M Meijer; Peter J F Snijders; Renske D M Steenbergen; Saskia M Wilting
Journal:  Clin Epigenetics       Date:  2018-06-07       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.